Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LLY compared with QTTB: revenue, margins and what each company keeps, and the suppliers and customers both name
LLY
ELI Lilly & Co
Change
Mkt cap
Revenue
Revenue
QTTB
Q32 Bio Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LLY
ELI Lilly & Co
vs
QTTB
Q32 Bio Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Revenue flow
Desk
News
Calendar
Saved
Search
LLY
ELI Lilly & Co
Change
1,368.91
▲
+0.31%
Mkt cap
$1.2T
Revenue
$24.4B
Q3 FY26
Revenue
$65.2B
FY25
QTTB
Q32 Bio Inc.
Change
9.18
▲
+3.71%
Regular session
Nov 6 '26
Mkt cap
$264.8M
Revenue
$54M
Q4 FY25
Revenue
—
vs
Compare
Regular session
Nov 6 '26
LLY
ELI Lilly & Co
vs
QTTB
Q32 Bio Inc.
1,368.91
▲
+0.31%
Price
9.18
▲
+3.71%
$1.2T
Mkt cap
$264.8M
Q3 FY26
$24.4B
Revenue
$54M
Q4 FY25
FY25
$65.2B
Revenue
—
Change
Change
LLY
1,368.91
▲
+0.31%
vs
QTTB
9.18
▲
+3.71%
Regular session
Nov 6 '26
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Price
Supply-chain overlap
Revenue flow
QTTB: latest quarter not drawable.
Method
›
Supply-chain overlap
direct ties · both sides
Sources
›
direct ties · both sides
Only LLY
29
MCK
McKesson
customer
CAH
Cardinal Health
customer
VEEV
Veeva Systems
supplier
UTHR
United Therapeutics
customer
25 more · LLY chain
›
Shared
0
No shared counterparties.
Only QTTB
6
BMY
Bristol-Myers Squibb Company ("BMS")
supplier
AKBA
Akebia Therapeutics, Inc. ("Akebia")
customer
—
The Regents of the University of Colorado ("Colorado")
unlisted
supplier
—
Role chip = supplier or customer
—
= no ticker (unlisted)
Source: SEC EDGAR
Horizon Therapeutics Ireland DAC
unlisted
supplier
2 more · QTTB chain
›
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LLY, solid
QTTB, dashed